US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 27.980
  • +0.720+2.64%
Close Nov 1 16:00 ET
  • 27.980
  • 0.0000.00%
Post 20:02 ET
3.41BMarket Cap-10286P/E (TTM)

Apellis Pharmaceuticals Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Nov 3, 2024

Based on 19 analysts giving stock ratings to Apellis Pharmaceuticals in the past 3 months

Buy

  • Buy

    73.68%
  • Hold

    26.32%
  • Sell

    0.00%

Price Target

Updated: Nov 3, 2024

The average Apellis Pharmaceuticals stock price target is 68.40 with a max estimate of 95.00 and a min estimate of 35.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Nov 3, 2024

Buy

  • Buy

    73.68%
  • Hold

    26.32%
  • Sell

    0.00%

Price Target

Updated: Nov 3, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data